trending Market Intelligence /marketintelligence/en/news-insights/trending/IhTjcEJUlmjyt3kjIF9D_A2 content esgSubNav
In This List

Catalyst plans common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Catalyst plans common stock offering

Catalyst Biosciences Inc. plans to offer common shares in an underwritten public offering.

Net proceeds will be used for general corporate purposes, including clinical trials, research and development activities, capital expenditures, selling, general and administrative costs, facilities expansion, and to meet working capital needs.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. are acting as joint book-running managers. LifeSci Capital LLC is acting as a co-manager for the proposed offering.